The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still's disease

被引：41

作者：

Zou, Yu-Qiong ^{[1
]}

Lu, Liang-Jing ^{[1
]}

Li, Shu-Jie ^{[1
]}

Zeng, Ting ^{[1
]}

Wang, Xiao-Dong ^{[1
]}

Bao, Chun-De ^{[1
]}

Chen, Shun-Le ^{[1
]}

Yang, Cheng-De ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Rheumatol, Shanghai 200001, Peoples R China

来源：

CLINICAL BIOCHEMISTRY | 2008年 / 41卷 / 7-8期

基金：

中国国家自然科学基金;

关键词：

macrophage migration inhibitory factor; adult-onset Still's disease;

D O I：

10.1016/j.clinbiochem.2008.01.008

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Objectives: This study investigated the levels of macrophage migration inhibitory factor (MIF) in adult-onset Still's disease (AOSD) and explored the role of this pro-inflammatory cytokine in the systemic inflammation of AOSD. Design and methods: Serum MIF levels were measured by ELISA in patients with AOSD and controls. Intracellular MIF production by peripheral blood leukocytes was detected by three-color flow cytometry. Results: Serum MIF levels were significantly increased in patients with AOSD. Serum MIF levels were significantly higher in AOSD patients with sore throat, myalgias, splenomegaly, or pleuritis, and were closely correlated with clinical disease severity and activity. Examined by flow cytometry, the intracellular MIF levels ill monocytes and T-lymphocytes from AOSD patients were significantly higher than those from healthy subjects. Conclusion: These data represent the first demonstration of increased MIF expression in AOSD, and suggest that MIF may be all important marker for disease evaluation and monitoring. (c) 2008 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

引用

页码：519 / 524

页数：6

共 39 条

[1] An essential regulatory role for macrophage migration inhibitory factor in T-cell activation [J].

Bacher, M ;

Metz, CN ;

Calandra, T ;

Mayer, K ;

Chesney, J ;

Lohoff, M ;

Gemsa, D ;

Donnelly, T ;

Bucala, R .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7849-7854

[2] MIF IS A PITUITARY-DERIVED CYTOKINE THAT POTENTIATES LETHAL ENDOTOXEMIA [J].

BERNHAGEN, J ;

CALANDRA, T ;

MITCHELL, RA ;

MARTIN, SB ;

TRACEY, KJ ;

VOELTER, W ;

MANOGUE, KR ;

CERAMI, A ;

BUCALA, R .

NATURE, 1993, 365 (6448) :756-759

[3] MECHANISM OF A REACTION IN VITRO ASSOCIATED WITH DELAYED-TYPE HYPERSENSITIVITY [J].

BLOOM, BR ;

BENNETT, B .

SCIENCE, 1966, 153 (3731) :80-&

[4] STILL,S DISEASE IN ADULT [J].

BYWATERS, EG .

ANNALS OF THE RHEUMATIC DISEASES, 1971, 30 (02) :121-+

[5] Macrophage migration inhibitory factor: A regulator of innate immunity [J].

Calandra, T ;

Roger, T .

NATURE REVIEWS IMMUNOLOGY, 2003, 3 (10) :791-800

[6] MIF AS A GLUCOCORTICOID-INDUCED MODULATOR OF CYTOKINE PRODUCTION [J].

CALANDRA, T ;

BERNHAGEN, J ;

METZ, CN ;

SPIEGEL, LA ;

BACHER, M ;

DONNELLY, T ;

CERAMI, A ;

BUCALA, R .

NATURE, 1995, 377 (6544) :68-71

[7] Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease [J].

Chen, DY ;

Lan, JL ;

Lin, FJ ;

Hsieh, TY ;

Wen, MC .

ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (10) :1300-1306

[8]

Choi JH, 2003, J RHEUMATOL, V30, P2422

[9] DELAYED HYPERSENSITIVITY IN VITRO - ITS MEDIATION BY CELL-FREE SUBSTANCES FORMED BY LYMPHOID CELL-ANTIGEN INTERACTION [J].

DAVID, JR .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1966, 56 (01) :72-&

[10] Development of chronic colitis is dependent on the cytokine MIF [J].

de Jong, YP ;

Abadia-Molina, AC ;

Satoskar, AR ;

Clarke, K ;

Rietdijk, ST ;

Faubion, WA ;

Mizoguchi, E ;

Metz, CN ;

Al Sahli, M ;

ten Hove, T ;

Keates, AC ;

Lubetsky, JB ;

Farrell, RJ ;

Michetti, P ;

van Deventer, SJ ;

Lolis, E ;

David, JR ;

Bhan, AK ;

Terhorst, C .

NATURE IMMUNOLOGY, 2001, 2 (11) :1061-1066

← 1 2 3 4 →